Radiopharmaceuticals Market By Product (Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Rubidium-82, and Others), Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Neurology, Cardiology, Oncology, and Others), End-user (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Cancer Research Institutes, and Others), and Region - Market Perspective, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecast for 2023 – 2032

Table Of Contents

Chapter 1. Executive Summary

Chapter 2. Research Methodology

2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary sources
2.3.1.1. Preliminary data mining
2.3.2. Primary sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook

3.1. Introduction
3.2. Key trends
3.2.1. Proliferating Demand for Enhanced Imaging and Diagnostic Techniques Augments the Market Growth
3.3. Market drivers
3.3.1. Growing Prevalence of Chronic Diseases Propels the Need for Radiopharmaceuticals
3.4. Market restraints
3.4.1. High Cost of Production Restricts the Market Growth
3.5. Market opportunities
3.5.1. Rising Number of Research & Development activities Provides Lucrative Opportunities for the Market Growth
3.6. Market Challenges
3.6.1. Preparation and Dispensing Problems Associated with Radiopharmaceuticals Pose a Challenge for the Market Growth
3.7. Porter’s Five Forces Analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis

Chapter 4. COVID-19 Impact on Global Radiopharmaceuticals Market

Chapter 5. Global Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)

5.1. Global Radiopharmaceuticals Market Share, By Product, 2018 - 2032 (USD Million)
5.1.1. Technetium-99
5.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.2. Fluorine-18
5.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.3. Iodine-131
5.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.4. Leutetium-177
5.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.5. Yttrium-90
5.1.5.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.6. Gallium-68 
5.1.6.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.7. Rubidium-82
5.1.7.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.7.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.8. Others
5.1.8.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.8.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 6. Global Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)

6.1. Global Radiopharmaceuticals Market Share, By Type, 2018 - 2032 (USD Million)
6.1.1. Diagnostic Nuclear Medicine
6.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
6.1.2. Therapeutic Nuclear Medicine
6.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 7. Global Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)

7.1. Global Radiopharmaceuticals Market Share, By Application, 2018 - 2032 (USD Million)
7.1.1. Neurology
7.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
7.1.2. Cardiology
7.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
7.1.3. Oncology
7.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 8. Global Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)

8.1. Global Radiopharmaceuticals Market Share, By End-user, 2018 - 2032 (USD Million)
8.1.1. Hospitals
8.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.2. Ambulatory Surgical Centers
8.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.3. Diagnostic Centers
8.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.4. Cancer Research Institutes
8.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.5. Others
8.1.5.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.5.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 9. Global Radiopharmaceuticals Market Overview, By Geography, 2018 - 2032 (USD Million)

9.1. Global Radiopharmaceuticals Market Share, By Geography, 2018 - 2032 (USD Million)
9.1.1. Market size and projections, by Countries, 2018 - 2032 (USD Million)
9.1.2. Market Share and CAGR Comparison, by Countries, 2022 - 2032 (%)

Chapter 10. North America Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)

10.1. North America Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
10.1.1. Market Size and projections, 2018 - 2032 (USD Million)
10.1.2. North America Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
10.1.3. North America Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
10.1.4. North America Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
10.1.5. North America Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
10.1.6. North America Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)
10.1.6.1. U.S. Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
10.1.6.1.1. Market Size and projections, 2018 - 2032 (USD Million)
10.1.6.1.2. U.S. Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
10.1.6.1.3. U.S. Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
10.1.6.1.4. U.S. Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
10.1.6.1.5. U.S. Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
10.1.6.2. Canada Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
10.1.6.2.1. Market Size and projections, 2018 - 2032 (USD Million)
10.1.6.2.2. Canada Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
10.1.6.2.3. Canada Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
10.1.6.2.4. Canada Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
10.1.6.2.5. Canada Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
10.1.6.3. Mexico Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
10.1.6.3.1. Market Size and projections, 2018 - 2032 (USD Million)
10.1.6.3.2. Mexico Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
10.1.6.3.3. Mexico Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
10.1.6.3.4. Mexico Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
10.1.6.3.5. Mexico Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)

Chapter 11. Europe Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)

11.1. Europe Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
11.1.1. Market Size and projections, 2018 - 2032 (USD Million)
11.1.2. Europe Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.3. Europe Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.4. Europe Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.5. Europe Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
11.1.6. Europe Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)
11.1.6.1. Germany
11.1.6.1.1. Market Size and projections, 2018 - 2032 (USD Million)
11.1.6.1.2. Germany Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.6.1.3. Germany Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.6.1.4. Germany Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.6.1.5. Germany Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
11.1.6.2. France
11.1.6.2.1. Market Size and projections, 2018 - 2032 (USD Million)
11.1.6.2.2. France Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.6.2.3. France Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.6.2.4. France Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.6.2.5. France Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
11.1.6.3. UK
11.1.6.3.1. Market Size and projections, 2018 - 2032 (USD Million)
11.1.6.3.2. UK Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.6.3.3. UK Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.6.3.4. UK Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.6.3.5. UK Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
11.1.6.4. Italy
11.1.6.4.1. Market Size and projections, 2018 - 2032 (USD Million)
11.1.6.4.2. Italy Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.6.4.3. Italy Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.6.4.4. Italy Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.6.4.5. Italy Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
11.1.6.5. Spain 
11.1.6.5.1. Market Size and projections, 2018 - 2032 (USD Million)
11.1.6.5.2. Spain Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.6.5.3. Spain Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.6.5.4. Spain Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.6.5.5. Spain Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
11.1.6.6. Rest of Europe
11.1.6.6.1. Market Size and projections, 2018 - 2032
11.1.6.6.2. Rest of Europe Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
11.1.6.6.3. Rest of Europe Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
11.1.6.6.4. Rest of Europe Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
11.1.6.6.5. Rest of Europe Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)

Chapter 12. Asia Pacific Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)

12.1. Asia Pacific Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
12.1.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.2. Asia Pacific Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.3. Asia Pacific Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
12.1.4. Asia Pacific Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.5. Asia Pacific Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
12.1.6. Asia Pacific Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)
12.1.6.1. India
12.1.6.1.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.6.1.2. India Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.6.1.3. India Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
12.1.6.1.4. India Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.6.1.5. India Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
12.1.6.2. China
12.1.6.2.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.6.2.2. China Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.6.2.3. China Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
12.1.6.2.4. China Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.6.2.5. China Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
12.1.6.3. Japan
12.1.6.3.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.6.3.2. Japan Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.6.3.3. Japan Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
12.1.6.3.4. Japan Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.6.3.5. Japan Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
12.1.6.4. South Korea
12.1.6.4.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.6.4.2. South Korea Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.6.4.3. South Korea Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
12.1.6.4.4. South Korea Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.6.4.5. South Korea Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.6.5.2. Rest of Asia Pacific Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.6.5.3. Rest of Asia Pacific Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
12.1.6.5.4. Rest of Asia Pacific Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.6.5.5. Rest of Asia Pacific Radiopharmaceuticals Market Overview, Distribution Channel, 2018 - 2032 (USD Million)

Chapter 13. Middle East & Africa Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)

13.1. Middle East & Africa Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
13.1.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.2. Middle East & Africa Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.3. Middle East & Africa Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
13.1.4. Middle East & Africa Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.5. Middle East & Africa Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
13.1.6. Middle East & Africa Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)
13.1.6.1. GCC
13.1.6.1.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.6.1.2. GCC Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.6.1.3. GCC Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
13.1.6.1.4. GCC Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.6.1.5. GCC Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
13.1.6.2. South Africa
13.1.6.2.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.6.2.2. South Africa Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.6.2.3. South Africa Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
13.1.6.2.4. South Africa Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.6.2.5. South Africa Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.6.3.2. Rest of Middle East & Africa Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.6.3.3. Rest of Middle East & Africa Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
13.1.6.3.4. Rest of Middle East & Africa Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.6.3.5. Rest of Middle East & Africa Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)

Chapter 14. South America Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)

14.1. South America Radiopharmaceuticals Market Overview, 2018 - 2032 (USD Million)
14.1.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.2. South America Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.3. South America Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
14.1.4. South America Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.5. South America Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
14.1.6. South America Radiopharmaceuticals Market Overview, By Countries, 2018 - 2032 (USD Million)
14.1.7. Brazil
14.1.7.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.7.2. Brazil Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.7.3. Brazil Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
14.1.7.4. Brazil Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.7.5. Brazil Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
14.1.8. Argentina
14.1.8.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.8.2. Argentina Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.8.3. Argentina Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
14.1.8.4. Argentina Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.8.5. Argentina Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)
14.1.9. Rest of South America
14.1.9.1. Market Size and projections, 2018 - 2032
14.1.9.2. Rest of South America Radiopharmaceuticals Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.9.3. Rest of South America Radiopharmaceuticals Market Overview, By Type, 2018 - 2032 (USD Million)
14.1.9.4. Rest of South America Radiopharmaceuticals Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.9.5. Rest of South America Radiopharmaceuticals Market Overview, By End-user, 2018 - 2032 (USD Million)

Chapter 15. Competitive Landscape

15.1. Competitive environment, 2022
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. Recent development

Chapter 16. Key Vendor Analysis

16.1. Bayer AG
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Product Benchmarking
16.1.4. Recent initiatives
16.2. Cardinal Health
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Product Benchmarking
16.2.4. Recent initiatives
16.3. Eckert & Ziegler
16.3.1. Company overview
16.3.2. Financial performance
16.3.3. Product Benchmarking
16.3.4. Recent initiatives
16.4. GE Healthcare
16.5. Jubilant Pharma Limited
16.6. NorthStar Medical Radioisotopes, LLC
16.7. Novartis AG
16.8. NTP Radioisotopes SOC Ltd
16.9. Siemens Healthineers
16.10. Telix Pharmaceuticals Limited
16.11. Others

Chapter 17. Sourcing Strategy and Downstream Buyers

17.1. Radiopharmaceuticals Market Industrial Chain Analysis
17.2. Downstream Buyers

Chapter 18. Marketing Strategy Analysis, Distributors/Traders

18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List

Chapter 19. Market Effect Factors Analysis

19.1. Product Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Product Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change

Chapter 20. Future Outlook of the Market

List of Figures

1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Radiopharmaceuticals Market share, By Product, 2023 & 2032 (%)
10. Global Radiopharmaceuticals Market share, by Technetium-99, By Product, 2018 - 2032 (USD Million)
11. Global Radiopharmaceuticals Market share, by Fluorine-18, By Product, 2018 - 2032 (USD Million)
12. Global Radiopharmaceuticals Market share, by Iodine-131, By Product, 2018 - 2032 (USD Million)
13. Global Radiopharmaceuticals Market share, by Leutetium-177, By Product, 2018 - 2032 (USD Million)
14. Global Radiopharmaceuticals Market share, by Yttrium-90, By Product, 2018 - 2032 (USD Million)
15. Global Radiopharmaceuticals Market share, by Gallium-68, By Product, 2018 - 2032 (USD Million)
16. Global Radiopharmaceuticals Market share, by Rubidium-82, By Product, 2018 - 2032 (USD Million)
17. Global Radiopharmaceuticals Market share, by Others, By Product, 2018 - 2032 (USD Million)
18. Global Radiopharmaceuticals Market share, By Type, 2023 & 2032 (%)
19. Global Radiopharmaceuticals Market share, by Diagnostic Nuclear Medicine, By Type, 2018 - 2032 (USD Million)
20. Global Radiopharmaceuticals Market share, by Therapeutic Nuclear Medicine, By Type, 2018 - 2032 (USD Million)
21. Global Radiopharmaceuticals Market share, By Application, 2023 & 2032 (%)
22. Global Radiopharmaceuticals Market share, by Neurology, By Application, 2018 - 2032 (USD Million)
23. Global Radiopharmaceuticals Market share, by Cardiology, By Application, 2018 - 2032 (USD Million)
24. Global Radiopharmaceuticals Market share, by Oncology, By Application, 2018 - 2032 (USD Million)
25. Global Radiopharmaceuticals Market share, by Others, By Application, 2018 - 2032 (USD Million)
26. Global Radiopharmaceuticals Market share, By End-user, 2023 & 2032 (%)
27. Global Radiopharmaceuticals Market share, by Hospitals, By End-user, 2018 - 2032 (USD Million)
28. Global Radiopharmaceuticals Market share, by Ambulatory Surgical Centers, By End-user, 2018 - 2032 (USD Million)
29. Global Radiopharmaceuticals Market share, by Diagnostic Centers, By End-user, 2018 - 2032 (USD Million)
30. Global Radiopharmaceuticals Market share, by Cancer Research Institutes, By End-user, 2018 - 2032 (USD Million)
31. Global Radiopharmaceuticals Market share, by Others, By End-user, 2018 - 2032 (USD Million)
32. Global Radiopharmaceuticals Market share, by region, 2023 & 2032 (%)
33. Global Radiopharmaceuticals Market share, by region, 2018 - 2032 (USD Million)
34. North America Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
35. North America Radiopharmaceuticals Market share, by Countries, 2023 & 2032 (%)
36. U.S. Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
37. Canada Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
38. Mexico Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
39. Europe Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
40. Europe Radiopharmaceuticals Market share, by Countries, 2023 & 2032 (%)
41. Spain Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
42. UK Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
43. Italy Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
44. Germany Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
45. France Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
46. Rest of Europe Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
47. Asia-Pacific Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
48. Asia-Pacific Radiopharmaceuticals Market share, by Countries, 2023 & 2032 (%)
49. China Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
50. India Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
51. Australia Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
52. Japan Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
53. Rest of Asia-Pacific Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
54. Middle East & Africa Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
55. Middle East & Africa Radiopharmaceuticals Market share, by Countries, 2023 & 2032 (%)
56. GCC Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
57. South Africa Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
58. Rest of Middle East & Africa Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
59. South America Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
60. Brazil Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
61. Argentina Radiopharmaceuticals Market, 2018 - 2032 (USD Million)
62. Rest of South America Radiopharmaceuticals Market, 2018 - 2032 (USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Radiopharmaceuticals Market, 2018 - 2032 (USD Million) 
4. Global Radiopharmaceuticals Market, by country, 2018 - 2032, (USD Million) 
5. North America Radiopharmaceuticals Market, By Product, 2018 - 2032 (USD Million)
6. North America Radiopharmaceuticals Market, By Type, 2018 - 2032 (USD Million)
7. North America Radiopharmaceuticals Market, By Application, 2018 - 2032 (USD Million)
8. North America Radiopharmaceuticals Market, By End-user, 2018 - 2032 (USD Million)
9. Europe Radiopharmaceuticals Market, By Product, 2018 - 2032 (USD Million)
10. Europe Radiopharmaceuticals Market, By Type, 2018 - 2032 (USD Million)
11. Europe Radiopharmaceuticals Market, By Application, 2018 - 2032 (USD Million)
12. Europe Radiopharmaceuticals Market, By End-user, 2018 - 2032 (USD Million)
13. Asia Pacific Radiopharmaceuticals Market, By Product, 2018 - 2032 (USD Million) 
14. Asia Pacific Radiopharmaceuticals Market, By Type, 2018 - 2032 (USD Million)
15. Asia Pacific Radiopharmaceuticals Market, By Application, 2018 - 2032 (USD Million)
16. Asia Pacific Radiopharmaceuticals Market, By End-user, 2018 - 2032 (USD Million)
17. Middle East & Africa Radiopharmaceuticals Market, By Product, 2018 - 2032 (USD Million)
18. Middle East & Africa Radiopharmaceuticals Market, By Type, 2018 - 2032 (USD Million) 
19. Middle East & Africa Radiopharmaceuticals Market, By Application, 2018 - 2032 (USD Million) 
20. Middle East & Africa Radiopharmaceuticals Market, By End-user, 2018 - 2032 (USD Million)
21. South America Radiopharmaceuticals Market, By Product, 2018 - 2032 (USD Million) 
22. South America Radiopharmaceuticals Market, By Type, 2018 - 2032 (USD Million) 
23. South America Radiopharmaceuticals Market, By Application, 2018 - 2032 (USD Million) 
24. South America Radiopharmaceuticals Market, By End-user, 2018 - 2032 (USD Million)
25. Global Radiopharmaceuticals Market, Company Market Share, 2022 - 2032 (%)
26. Bayer AG: Product Benchmarking
27. Bayer AG: Financial Performance
28. Cardinal Health: Product Benchmarking
29. Cardinal Health: Financial Performance
30. Eckert & Ziegler: Product Benchmarking
31. Eckert & Ziegler: Financial Performance
32. GE Healthcare: Product Benchmarking
33. GE Healthcare: Financial Performance
34. Jubilant Pharma Limited: Product Benchmarking
35. Jubilant Pharma Limited: Financial Performance
36. NorthStar Medical Radioisotopes, LLC: Product Benchmarking
37. NorthStar Medical Radioisotopes, LLC: Financial Performance
38. Novartis AG: Product Benchmarking
39. Novartis AG: Financial Performance
40. NTP Radioisotopes SOC Ltd: Product Benchmarking
41. NTP Radioisotopes SOC Ltd: Financial Performance
42. Siemens Healthineers: Product Benchmarking
43. Siemens Healthineers: Financial Performance
44. Telix Pharmaceuticals Limited: Product Benchmarking
45. Telix Pharmaceuticals Limited: Financial Performance